NCT00527462已完成不适用
Mono-Center, Double-Blind, Cross-Over Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles Versus Filtered Air on Airway Inflammation Induced by Segmental Allergen Challenge in Asthmatics
Fraunhofer-Institute of Toxicology and Experimental Medicine2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2007年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- difference of the number of total cells in bronchoalveolar lavage resulting in the comparison of allergenic versus control segments
研究概览
简要总结
The aim of the study is to test the hypothesis that the allergic airway inflammation in asthmatic patients will be enhanced after exposure to ultrafine particles (UFP). In order to test this in a controlled study, the researchers combine controlled exposure to carbon black model UFP with the well-established model of a segmental allergen challenge, which allows the researchers to safely induce circumscript allergic inflammation in the lung in mild asthmatics. The effect of the UFP on allergic inflammation will be controlled by an inhalation of clean air in a randomized, double-blind, crossover design.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female subjects, aged 18-45 years.
- •Women will be considered for inclusion if they are:
- •Not pregnant, as confirmed by a pregnancy test and not nursing.
- •Not of child-bearing capacity (i.e. physiologically incapable of becoming pregnant, including any female who is pre-menarchial or post-menopausal, with documented proof of hysterectomy or tubal ligation, or meets clinical criteria for menopause and has been amenorrheal for more than 1 year prior to the screening visit).
- •Of child-bearing capacity and using a highly effective method of contraception during the entire study (vasectomised partner, sexual abstinence [the lifestyle of the female should be such that there is complete abstinence from intercourse two weeks prior to the first dose of study medication until at least 72 hours after treatment], implants, injectables, combined oral contraceptives, hormonal intrauterine devices [IUDs]).
- •Physician diagnosis of mild intermittent seasonal asthma
- •Non-smokers, or ex-smokers
- •Forced expiratory volume in 1 second (FEV1) > 80% of the predicted value
- •Positive skin prick test for grass mix at or within 12 months prior to the screening visit
- •Able and willing to give written informed consent to take part in the study
- •Available to complete all study measurements
- •Able to restrain from particle rich atmosphere (e.g. passive cigarette smoke) within 1 week before exposure to UFP or clean air
排除标准
- •Infections of the respiratory tract within the last month
- •Past or present disease which, as judged by the investigator, may affect the outcome of this study. These diseases include, but are not limited to, cardiovascular disease, malignancy, hepatic disease, renal disease, hematological disease, neurological disease, endocrine disease or pulmonary disease (including but not confined to chronic bronchitis, emphysema, tuberculosis, bronchiectasis or cystic fibrosis).
- •Pathological findings in safety laboratory tests
- •Subjects with clinically relevant infection or known ongoing clinically relevant inflammatory process
- •Suspected hypersensitivity to any ingredients of the medication involved with bronchoscopy (bronchodilators, sedatives and local anaesthetics)
- •Specific immunotherapy (SIT) within two years prior to the study
- •Administration of oral, injectable, or dermal corticosteroids according to 9.2
- •Neurological or psychiatric disease or history of drug or alcohol abuse which would interfere with the subject's proper completion of the protocol assignment
- •Risk of non-compliance with study procedures
- •Participation in another clinical trial 30 days prior to enrolment
- •Suspected inability to understand the protocol requirements, instructions and study-related restrictions, the nature, scope, and possible consequences of the study.
- •Unlikely to comply with the protocol requirements, instructions and study-related restrictions; e.g., language problems, uncooperative attitude, inability to return for follow-up visits, and improbability of completing the study
结局指标
主要结局
difference of the number of total cells in bronchoalveolar lavage resulting in the comparison of allergenic versus control segments
时间窗: 24 hours
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)AsthmaNCT01193049Merck Sharp & Dohme LLC11
已完成
3 期
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)Asthma, BronchialRhinitis, Allergic, PerennialNCT00092105Organon and Co58
已完成
3 期
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)AsthmaNCT00092144Organon and Co500
进行中（未招募）
不适用
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma PatientsAsthmaNCT06605885AstraZeneca202
已完成
2 期
Safety and Efficacy of an H1N1 Influenza Vaccine in People With AsthmaH1N1 Influenza VirusNCT00978120National Institute of Allergy and Infectious Diseases (NIAID)390